Zantac -- also known as ranitidine -- was a popular heartburn drug until 2020, when the Food and Drug Administration ordered it removed from pharmacy shelves because of a potential cancer risk. While ...
The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...
A D.C. drugmaker has been dealt a major setback in its long-running bid to bring its treatment for a chronic gastrointestinal ...
The U.S. Food and Drug Administration has declined to approve Vanda Pharmaceuticals' drug to treat stomach paralysis symptoms ...
Medpage Today on MSN6d
First Drug OK'd for Chronic Rhinosinusitis With Nasal Polyps in AdolescentsThe FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal ...
The Food and Drug Administration (FDA) has accepted the resubmitted New Drug Application (NDA) for AXS-07 for the acute treatment of migraine. AXS-07 is an oral agent that consist ...
Twice-yearly lenacapavir was found to be superior to daily emtricitabine 200mg and tenofovir disoproxil fumarate 300mg.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback